title: A slow RNA polymerase II affects alternative splicing in vivo.
abstract: Changes in promoter structure and occupation have been shown to modify the splicing pattern of several genes, evidencing a coupling between transcription and alternative splicing. It has been proposed that the promoter effect involves modulation of RNA pol II elongation rates. The C4 point mutation of the Drosophila pol II largest subunit confers on the enzyme a lower elongation rate. Here we show that expression of a human equivalent to Drosophila's C4 pol II in human cultured cells affects alternative splicing of the fibronectin EDI exon and adenovirus E1a pre-mRNA. Most importantly, resplicing of the Hox gene Ultrabithorax is stimulated in Drosophila embryos mutant for C4, which demonstrates the transcriptional control of alternative splicing on an endogenous gene. These results provide a direct proof for the elongation control of alternative splicing in vivo.
authors.affiliation: Laboratorio de Fisiología y Biología Molecular, Departamento de Fisiología, Biología Molecular y Celular, IFIBYNE-CONICET, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, Buenos Aires, Argentina.
authors.forename: Manuel
authors.initials: M
authors.lastname: de la Mata
authors.forename: Claudio R
authors.initials: CR
authors.lastname: Alonso
authors.forename: Sebastián
authors.initials: S
authors.lastname: Kadener
authors.forename: Juan P
authors.initials: JP
authors.lastname: Fededa
authors.forename: Matías
authors.initials: M
authors.lastname: Blaustein
authors.forename: Federico
authors.initials: F
authors.lastname: Pelisch
authors.forename: Paula
authors.initials: P
authors.lastname: Cramer
authors.forename: David
authors.initials: D
authors.lastname: Bentley
authors.forename: Alberto R
authors.initials: AR
authors.lastname: Kornblihtt
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D017500:Adenovirus E1A Proteins / Q000235:genetics; D017398:Alternative Splicing; D000546:Amanitins / Q000494:pharmacology; D000818:Animals; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D029721:Drosophila Proteins / Q000235:genetics; D004331:Drosophila melanogaster; D005091:Exons; D005353:Fibronectins / Q000378:metabolism; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D008954:Models, Biological; D008957:Models, Genetic; D010957:Plasmids / Q000378:metabolism; D017354:Point Mutation; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms; D012313:RNA / Q000378:metabolism; D012319:RNA Polymerase II / Q000737:chemistry* / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012260:Ribonucleases / Q000378:metabolism; D013997:Time Factors; D014157:Transcription Factors / Q000235:genetics; D014162:Transfection
chemical_list: D017500:Adenovirus E1A Proteins; D000546:Amanitins; D029721:Drosophila Proteins; D005353:Fibronectins; D018398:Homeodomain Proteins; D020033:Protein Isoforms; D012333:RNA, Messenger; D014157:Transcription Factors; C066177:Ubx protein, Drosophila; D012313:RNA; D012319:RNA Polymerase II; D012260:Ribonucleases